Shamim Ruff

Affiliations

  • Director at Reata Pharmaceuticals Inc (RETA), 2023-09-26
  • Svp, Chief Regulatory Affairs at Sarepta Therapeutics Inc. (SRPT), 2018-05-24
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RETA $164.53 8,235 $1,354,887.26 7,359 2023-07-28 Filing
RETA $83.73 5,740 $480,610.20 5,223 2023-03-10 Filing
SRPT $55.00 10,000 $550,000.00 27,045 2017-11-06 Filing
SRPT $50.00 11,500 $575,000.00 27,045 2017-10-03 Filing
SRPT $44.00 1,500 $66,000.00 21,062 2017-07-21 Filing